PAIN

IceCure's ProSense® a Promising Alternative Treatment for Extra-Pelvis Endometriosis: Independent Study Presented at ECR 2024

Retrieved on: 
Monday, March 4, 2024
Woman, PAIN, Neoplasm, Teaching hospital, Patient satisfaction, Abdominal wall, Endometriosis, Freezing, Visual analogue scale, Safety, Patient, MRI, Medical imaging

Five doctors participated in the study, including interventional radiologist and ProSense® user Prof. Julien Frandon, who has previously led hands-on training sessions with ProSense® at multiple medical conferences.

Key Points: 
  • Five doctors participated in the study, including interventional radiologist and ProSense® user Prof. Julien Frandon, who has previously led hands-on training sessions with ProSense® at multiple medical conferences.
  • The investigator-initiated single-site study enrolled 7 women, ages 30-45 years, with endometriosis in the abdominal wall and para-diaphragmatic areas.
  • One month following treatment, assessment by MRI revealed hemorrhagic signal had disappeared and necrotic changes developed.
  • We are very pleased that all patients treated in this study were relieved of their endometriosis condition and pain within as little as a month following treatment," stated IceCure CEO Eyal Shamir.

Voices for Non-Opioid Choices Coalition Applauds Introduction of Alternatives to PAIN Act in Senate

Retrieved on: 
Thursday, February 29, 2024
PAIN, Opioid, Addiction, Pain, Drug, Risk, House, Pain management, Medicare, Patient, Medicare Part D, Representative, Alternatives, Senate, Health insurance

WASHINGTON, Feb. 29, 2024 /PRNewswire/ -- Today, the Senate took a crucial step forward in the fight to prevent opioid addiction by introducing the bipartisan Alternatives to Prevent Addiction in the Nation (PAIN) Act. The Alternatives to PAIN Act will ensure that all Americans can access safe, effective, non-addictive pain management approaches. In the process, the Alternatives to PAIN Act can prevent opioid addiction that occurs following an acute pain incident and save lives.

Key Points: 
  • The Alternatives to PAIN Act will ensure that all Americans can access safe, effective, non-addictive pain management approaches.
  • In the process, the Alternatives to PAIN Act can prevent opioid addiction that occurs following an acute pain incident and save lives.
  • "Over one million American seniors are diagnosed with opioid addiction every year," said Chris Fox, Executive Director of the Voices for Non-Opioid Choices Coalition .
  • In January, Representative Mariannette Miller-Meeks (R-IA) and Representative Tony Cárdenas (D-CA) introduced companion legislation, The Alternatives to PAIN Act (H.R.

InventHelp Inventor Develops Versatile Pain Management System (NJD-2560)

Retrieved on: 
Tuesday, September 5, 2023
Ankle, TENS, Osteoarthritis, Human, Elbow, Wrist, Arthritis, Multimedia, Neck, Sale, UNIVERSAL, Pain, Brace, Joint, PAIN, Knee, Dentistry

My design offers a versatile pain relief system and it could allow the user to relax, venture outdoors, or complete various tasks during use."

Key Points: 
  • My design offers a versatile pain relief system and it could allow the user to relax, venture outdoors, or complete various tasks during use."
  • The invention provides a pain management system designed to accommodate various areas of the body.
  • In doing so, it can be used on various joints in pain such as the ankle, knee, wrist, elbow, neck, and back.
  • As a result, it helps reduce pain and it eliminates the need to purchase numerous bulky braces.

Houston dermatologist develops new class of topical pain-relieving pharmaceuticals

Retrieved on: 
Friday, September 1, 2023
Dermatitis, Anti-inflammatory, Dermatology, Multimedia, Aloe vera, Cosmetics, HARD, OTC, PAIN, Lotion

HOUSTON, Sep. 01, 2023 /PRNewswire/ -- Dr. Milton D. Moore, a leading dermatologist and founder & CEO of Moore Unique Skin Care, LLC and Moore Unique Dermatology, has introduced two new products under the brand name Moore Relief Dermaceuticals: Moore Relief Pain Discomfort Lotion and Moore Relief Skin Revitalizing & Burn Lotion. Initially formulated as moisturizing treatments for eczema and other conditions that cause skin irritation. Moore Relief Pain Discomfort Lotion and Moore Relief Skin Revitalizing & Burn Lotion are fast-acting, effective therapies that help relieve neuropathic skin discomfort, and helps heal burn wounds.

Key Points: 
  • The products will launch and be available for purchase with an amazing launch special price reduction of 51% on www.moorerelief.com on Thursday, August 31, 2023.
  • HOUSTON, Sep. 01, 2023 /PRNewswire/ -- Dr. Milton D. Moore, a leading dermatologist and founder & CEO of Moore Unique Skin Care, LLC and Moore Unique Dermatology , has introduced two new products under the brand name Moore Relief Dermaceuticals: Moore Relief Pain Discomfort Lotion and Moore Relief Skin Revitalizing & Burn Lotion.
  • Moore Relief Pain Discomfort Lotion and Moore Relief Skin Revitalizing & Burn Lotion are fast-acting, effective therapies that help relieve neuropathic skin discomfort, and helps heal burn wounds.
  • Each ingredient provides a unique contribution to the effectiveness of the products by cooling, moisturizing, and repairing damaged skin areas.

InventHelp Inventor Develops All-Natural Healing Balm (AJD-148)

Retrieved on: 
Monday, August 7, 2023
Stiffness, Multimedia, Inflammation, Sale, Pain, PAIN, Chronic pain, Skin, Poultry farming, Atlanta

I also had trouble sleeping and thought if there were a simple pain reief formula to help," said an inventor, from Mcdonough, Ga., "so I invented the " MIRACLE WORKER " PAIN BUTTER.

Key Points: 
  • I also had trouble sleeping and thought if there were a simple pain reief formula to help," said an inventor, from Mcdonough, Ga., "so I invented the " MIRACLE WORKER " PAIN BUTTER.
  • My formula helps to reduce pain from achy joints and muscles, inflammation discomfort, and other conditions."
  • The patent-pending invention provides a new formula for treating joint and muscle pain, inflammation, stiffness, etc.
  • 21-AJD-148, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.

BAILEY HOUSE ANNOUNCES INAUGURAL "ART HOUSE" BENEFIT

Retrieved on: 
Monday, June 5, 2023
Bailey House, Poverty, HIV/AIDS, The Bowery Hotel, Partnership, Housing, HOUSE, Homelessness, HIV, ART, Denver 2008 Convention Host Committee, Amida Care, New Yorker, Charitybuzz, AIDS, Conditional sentence, Bailey House (charity), Housing Works, PAIN, Mental health, Auction

NEW YORK, June 5, 2023 /PRNewswire/ -- Bailey House, a leading community based organization dedicated to providing housing and supportive services for people living with HIV/AIDS and other chronic illness, will host the inaugural ART HOUSE benefit on June 14, 2023 at the Bowery Hotel. ART HOUSE, serving as a reinvention of the Bailey House Gala + Auction, will bring together art world insiders, supporters, and the philanthropic community for a cocktail party, auction, and awards presentation spotlighting visionary leaders in the fight to end homelessness and AIDS in NYC.

Key Points: 
  • Proceeds from the auction will benefit the Bailey House, which has been addressing poverty, homelessness, mental health, substance use, and chronic illness among low-income New Yorkers for nearly four decades.
  • In January 2019, Bailey House merged with Housing Works, the nation's leading HIV/AIDS advocacy and service organization.
  • As part of the merger, all housing development for the combined entity now takes place under Bailey House.
  • Cocktail Reception + Awards Presentation: 6-9PM
    About Bailey House: Founded in 1983, Bailey House provides comprehensive housing and supportive services for marginalized New Yorkers affected by HIV/AIDS and other chronic illnesses.

Research Describes Novel Laboratory Automation Platform for Preclinical Detection and Quantification of Behavior

Retrieved on: 
Wednesday, March 8, 2023
IASP, Department of Neurobiology, Harvard Medical School, Acquisition, Machine learning, Medicine, Boston Children's Hospital, BCH, Nervous system, FTIR, Analgesic, Behavior, International Association, Pain, International Association for the Study of Pain, Harvard Medical School, Hospital, Doctor of Philosophy, Safety, Medical imaging, DALLAS, Neuroscience, PAIN

BOSTON and DALLAS, March 8, 2023 /PRNewswire/ -- Researchers at Boston Children's Hospital and Harvard Medical School's Department of Neurobiology have developed a new approach to measure dynamic changes in behavior in an unbiased, observer-independent manner, according to a new study published in and featured on the cover of PAIN, the journal of the International Association for the Study of Pain (IASP). The investigators noted that this technology platform has the ability to characterize a broad range of physiological and pathological phenomena and can be applied to objectively and automatically characterize behaviors including such tactile hyperalgesia, sedation, and other neurological readouts.

Key Points: 
  • Results suggest new technology enables improved, high-volume characterization and quantification of in vivo behavior.
  • Principal Investigator, Clifford Woolf, Mb, BCh, PhD, Professor of Neurobiology at Harvard Medical School and Director of the F.M.
  • Kirby Neurobiology Center at Boston Children's Hospital
    This peer-reviewed study demonstrated the efficacy of a novel automated technology platform in recording freely behaving mice over time for continuous data acquisition.
  • In addition, researchers utilized a proprietary machine learning software for automatic extraction and quantification of behavior characters, allowing for objective, sensitive, and high-throughput measurement of the behavioral state of rodents.

Healing Sounds, Rest, Fitness for Emotional Wellbeing…RoundGlass Identifies Wellness Trends for 2023

Retrieved on: 
Tuesday, January 24, 2023
Well, Athlete, Meditation, Inflammation, Spirituality, Mental health, Dementia, Pain, Life, Traction, Relaxation, Health, HIIT, Stranger Things, DSM-IV codes, PAIN, Emotion: Side B, Sleep, Food, Cryotherapy, Sound, Brain, RoundGlass Foundation, Divine Intervention, Call-progress tone, Yoga, Lead, Holism, Myalgia, Migraine, Mindfulness, High-intensity interval training, Anxiety, Prakṛti, Music, Depression, Perception, Research, Physical, Nursing

BELLEVUE, Wash., Jan. 23, 2023 /PRNewswire/ -- RoundGlass , a global Wholistic Wellbeing company has identified cutting-edge wellness trends for the year 2023.

Key Points: 
  • BELLEVUE, Wash., Jan. 23, 2023 /PRNewswire/ -- RoundGlass , a global Wholistic Wellbeing company has identified cutting-edge wellness trends for the year 2023.
  • The wellness trends have been identified by Prakriti and Dr David Vago, Lead Research at RoundGlass.
  • Furthermore, as a leader in the wellbeing space, RoundGlass's five new wellness trends for 2023 can be incorporated into one's daily life.
  • Some of these trends are:
    Immersive and Healing Sound: Healing through sound is expected to gain more traction in 2023.

Heron Therapeutics Announces Filing of an Efficacy Supplement for ZYNRELEF® and Provision in Newly Passed Congressional Bill Anticipated to Provide Separate Reimbursement Outside of the Packaged Surgical Payment for ZYNRELEF

Retrieved on: 
Monday, January 2, 2023
Aspirin, PAIN, CMS, Human, Patient, Elective surgery, Tears, Vomiting, SAN, Boxed warning, Drug discovery, Media contacts database, Liver, Head, Ibuprofen, Meloxicam, Headache, Media, Shanda, Ulcer, Allergy, Anemia, Stroke, Risk, Medicine, Medicare, Pharming, FDA, Safety, Cartilage, Degenerative disease, Death, News, Abdominoplasty, Foot, Ankle, Anesthetic, Constipation, Time-invariant system, Heron, Heart failure, Pain, Congress, Legislation, Nonsteroidal anti-inflammatory drug, Naproxen, Centers for Medicare & Medicaid Services, Gastrointestinal bleeding, New Drug Application, Bupivacaine, Pregnancy, Health insurance, Pharmaceutical industry, Frankincense

SAN DIEGO, Dec. 29, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced the submission of a supplemental New Drug Application (sNDA) for ZYNRELEF (bupivacaine and meloxicam) extended-release solution to support the proposed indication for greatly expanded use of ZYNRELEF in soft tissue and orthopedic surgical procedures and a newly passed congressional bill that is anticipated to provide separate reimbursement outside of the packaged surgical payment for ZYNRELEF for almost 3 years.

Key Points: 
  • 2617, the omnibus spending bill approved by Congress last week includes a provision (SEC.
  • In two Phase 3 trials, ZYNRELEF demonstrated the ability to significantly increase the proportion of patients taking no opioids after surgery and we believe it qualifies for this separate payment.
  • ZYNRELEF currently has pass-through status in the outpatient setting of care through March 31, 2025 and this provision should extend separate reimbursement outside of the packaged surgical payment through December 31, 2027.
  • Safety and efficacy have not been established in highly vascular surgeries, such as intrathoracic, large multilevel spinal, and head and neck procedures.

WCI Health LLC, Your Alternative Health and Wellness Hub Will Be a Vendor and Presenter at Wonderland Miami by Microdose

Retrieved on: 
Wednesday, October 5, 2022
Caregiver, Insurance, MAPS, Medicine, PAIN, Population, Conference, Science, Education, Patient, Depression, KETAMINE, WCI, Microdosing, Center, Health, Pharming, Awareness, Pain, Physical disability, Psilocybin, Clinical study design, Korea Disease Control and Prevention Agency, COVID-19, PTSD, Pharmaceutical industry, CBD, Cannabis

According to the Centers for Disease Control and Prevention, mental illness has become a big problem both in the United States and growing globally.

Key Points: 
  • According to the Centers for Disease Control and Prevention, mental illness has become a big problem both in the United States and growing globally.
  • WCI Health & WCI Health University's objective is to bring alternative health and wellness options to people through our quality plant-based products and educational programs.
  • At WCI Health, we help you level up your wellness journey using the healing powers of plant medicine!
  • Contact Dr. Lola to Sponsor WCI Health' BOOTH & PODCAST: